Filtros de búsqueda

Lista de obras de Roland B Walter

A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia

artículo científico publicado en 2013

A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

artículo científico publicado en 2017

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

artículo científico publicado en 2013

A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age.

artículo científico publicado en 2015

AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin

artículo científico publicado en 2013

Acidosis induced by lactate, pyruvate, or HCl increases blood viscosity

artículo científico publicado en 2002

Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies

artículo científico publicado en 2016

Acute, life-threatening hypoglycemia associated with haloperidol in a hematopoietic stem cell transplant recipient

artículo científico publicado en 2006

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study

artículo científico publicado en 2019

Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin

artículo científico publicado en 2013

Assessment of digital clubbing in medical inpatients by digital photography and computerized analysis.

artículo científico publicado en 2002

Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease

artículo científico publicado en 2008

Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort study

artículo científico publicado en 2013

Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia.

artículo científico publicado en 2014

Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-gamma1 in acute myeloid leukemia cells.

artículo científico publicado en 2004

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

artículo científico publicado en 2013

COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia

scientific article published on 11 September 2018

Cancer risk associated with long-term use of acetaminophen in the prospective VITamins and lifestyle (VITAL) study

artículo científico publicado en 2011

Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML.

artículo científico publicado en 2013

Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)

artículo científico publicado en 2020

Chronic myeloid leukemia in lymphoid blast crisis.

artículo científico publicado en 2014

Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid.

artículo científico publicado en 2015

Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual disease

scientific article published on 03 December 2019

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2020

Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study

artículo científico publicado en 2003

Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia

artículo científico publicado en 2014

Critical role of interleukin-1beta for transcriptional regulation of endothelial 6-pyruvoyltetrahydropterin synthase

artículo científico publicado en 2003

Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML.

artículo científico publicado en 2018

Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans

artículo científico publicado en 2003

Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia

artículo científico publicado en 2019

Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm

scientific article published on 04 October 2019

Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia

artículo científico publicado en 2015

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

artículo científico publicado en 2010

Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia

artículo científico publicado en 2015

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG.

artículo científico publicado en 2015

Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2

artículo científico publicado en 2018

Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia

artículo científico publicado en 2003

Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia

artículo científico publicado en 2014

Fatal hepatic veno-occlusive disease associated with terbinafine in a liver transplant recipient.

artículo científico publicado en 2003

Fatal necrotizing fasciitis due to Streptococcus pneumoniae after renal transplantation

artículo científico publicado en 2003

Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy

artículo científico publicado en 2014

Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission

artículo científico publicado en 2013

Functional expression of the CD163 scavenger receptor on acute myeloid leukemia cells of monocytic lineage.

artículo científico publicado en 2005

Gemcitabine-associated hemolytic-uremic syndrome

artículo científico publicado en 2002

Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study

artículo científico publicado en 2013

Height as an explanatory factor for sex differences in human cancer

artículo científico publicado en 2013

High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

artículo científico publicado en 2012

High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

artículo científico publicado en 2014

High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group

artículo científico publicado en 2010

How Do Pretransplantation Peripheral Blood Counts Inform Us about Post-Transplantation Outcomes in Acute Myeloid Leukemia?

artículo científico publicado en 2015

ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2

artículo científico publicado en 2008

Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome. ⬇️

artículo científico publicado en 2015

Images in clinical medicine. Vitiligo and pernicious anemia

artículo científico publicado en 2004

Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML

scientific article published on 23 January 2020

Impairment of blood rheology by cholestatic jaundice in human beings

artículo científico publicado en 2003

Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity

artículo científico publicado en 2004

Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.

artículo científico publicado en 2017

Letter regarding article by Vita et al, "serum myeloperoxidase levels independently predict endothelial dysfunction in humans"

artículo científico publicado en 2005

Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.

artículo científico publicado en 2015

Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia.

artículo científico publicado en 2014

Mechanism of Endocytosis of CD33/SIGLEC-3: Role of ITIMs, Tyrosine Phosphorylation, and Monoubiquitylation ⬇️

doctoral thesis by Roland Bruno Walter, 2006

Metastatic squamous cell carcinoma with marked blood eosinophilia and elevated serum interleukin-5 levels

artículo científico publicado en 2002

Minimal residual disease in acute myeloid leukemia--current status and future perspectives

artículo científico

Minimal residual disease-directed therapy in acute myeloid leukemia

artículo científico publicado en 2015

Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party.

artículo científico publicado en 2018

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study

artículo científico publicado en 2017

Mott cells

artículo científico publicado en 2012

Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells.

artículo científico publicado en 2003

Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

artículo científico publicado en 2015

Myeloid sarcoma of the heart.

artículo científico publicado en 2012

Need for routine examination of left ventricular ejection fraction in patients with AML

artículo científico publicado en 2019

Next-generation sequencing for measuring minimal residual disease in AML

scientific article published on 01 August 2018

Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative

artículo científico publicado en 2014

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission

artículo científico publicado en 2014

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2014

Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design

artículo científico publicado en 2014

Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study ⬇️

artículo científico publicado el 10 de marzo de 2011

Outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia

artículo científico publicado en 2013

Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms

artículo científico publicado en 2018

Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor

artículo científico publicado en 2007

Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission

scientific article published on 25 February 2019

Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia

scientific article published on 28 February 2014

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment

artículo científico publicado en 2011

Pretargeted radioimmunotherapy for hematologic and other malignancies

artículo científico publicado en 2010

Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.

artículo científico publicado en 2015

Quality of life from the perspective of the patient with acute myeloid leukemia

artículo científico publicado en 2017

Rapid detection of pathogenic fungi from clinical specimens using LightCycler real-time fluorescence PCR.

artículo científico publicado en 2003

Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia

artículo científico publicado en 2013

Refining AML outcome prediction

artículo científico publicado en 2018

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia

artículo científico publicado en 2015

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center.

artículo científico publicado en 2014

SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.

artículo científico publicado en 2013

Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion

artículo científico publicado en 2003

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials

artículo científico publicado en 2018

Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients

artículo científico publicado en 2013

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

artículo científico publicado en 2013

Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation.

artículo científico publicado en 2018

Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia

artículo científico publicado en 2017

Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation

scientific article published on 30 October 2019

Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization

artículo científico publicado en 2011

Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy

artículo científico publicado en 2021

The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity

scientific article published on 04 February 2020

The past and future of CD33 as therapeutic target in acute myeloid leukemia.

artículo científico publicado en 2014

The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin

artículo científico publicado en 2004

The power of comparative studies

scientific article published on 05 November 2008

The role of CD33 as therapeutic target in acute myeloid leukemia.

artículo científico publicado en 2014

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

artículo científico publicado en 2015

Update on antigen-specific immunotherapy of acute myeloid leukemia

artículo científico

Value of routine 'day 14' marrow exam in newly diagnosed AML

scientific article published on 10 September 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda